Twist bioscience

Twist Bioscience: Revolutionizing Synthetic Biology with Innovative DNA Synthesis

Twist Bioscience is a leading synthetic biology company that specializes in innovative silicon-based DNA synthesis. The company has developed a proprietary technology platform that enables the high-quality, cost-effective, and scalable production of synthetic DNA molecules for various applications in life sciences research, drug discovery, diagnostics, and industrial biotechnology.

Founded in 2013 by Emily Leproust and Bill Peck, Twist Bioscience has quickly established itself as a pioneer in the field of synthetic biology. The company's mission is to accelerate the pace of scientific discovery and innovation by providing researchers with access to custom-designed DNA sequences that can be used to create novel biological systems and products.

One of the key advantages of Twist Bioscience's technology platform is its ability to synthesize long strands of DNA with high accuracy and fidelity. This allows researchers to design complex genetic circuits and pathways that can be used for a wide range of applications such as gene therapy, protein engineering, metabolic engineering, and more.

In addition to its core gene synthesis services, Twist Bioscience also offers a range of other synthetic DNA tools such as oligo pools (collections of short DNA sequences), exome (the protein-coding regions of the genome), NGS target enrichment (a method for sequencing specific regions of interest), variant libraries (collections of genetic variants), among others.

The company's products have been widely adopted by academic researchers, biotech companies, pharmaceutical companies, government agencies, and other organizations around the world. Some notable applications include developing new cancer therapies based on CAR-T cells engineered with synthetic genes; creating novel enzymes for industrial processes; designing biosensors for environmental monitoring; improving crop yields through genetic modification; among many others.

Twist Bioscience has also formed strategic partnerships with leading companies in various industries such as Microsoft (to store digital data on synthetic DNA) and Ginkgo Bioworks (to develop new bio-based materials). These collaborations have further expanded the potential applications for Twist Bioscience's technology platform beyond traditional life sciences research.

Overall, Twist Bioscience is at the forefront of an exciting new era in synthetic biology where custom-designed genetic sequences are becoming increasingly accessible to researchers across different fields. With its innovative technology platform and commitment to quality service delivery at scale - it is no surprise why this Silicon Valley-based firm continues making waves within this industry!